← Leaderboards
John L Hamilton
Rush University Medical Center
$272,352
Attributed
$460,403
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $202.3K · FY2016–25$250K$187.5K$125K$62.5K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$460,403 · 2
By mechanism
R21$376,103 · 1
F31$84,300 · 1
Top collaborators
- Markus Anton Wimmer2 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Markus Anton Wimmer$2,962,737
- Anne-Marie Malfait$16,728,459
- Jian Huang$1,096,127
- Lan Zhao$880,142
- Chundo Oh$157,000
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingJointsPre-ClinicalReportingAntibodiesIntra-Articular InjectionsIn VivoPathogenesisTissuesSurfaceAggrecanAntibiotic ResistanceAntibioticsAntibiotic TherapyAnimalsAfferent NeuronsAdverse OutcomeAnimal ModelArticular CartilageArthritisAssesAttenuatedBacteriaAngiogenic Factor
Grant awards (4)
Use of Bacterial Biofilm Disrupting Antibodies to Prevent and Treat Periprosthetic Joint Infection$202,303
R21 · FY2025 · AR · contact PI
Use of Bacterial Biofilm Disrupting Antibodies to Prevent and Treat Periprosthetic Joint Infection$173,800
R21 · FY2024 · AR · contact PI
Anti-VEGF Therapy in Osteoarthritis and Associated Pain$40,724
F31 · FY2017 · AR · contact PI
Anti-VEGF Therapy in Osteoarthritis and Associated Pain$43,576
F31 · FY2016 · AR · contact PI